Filing Details

Accession Number:
0001213900-19-020722
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-10-21 16:23:29
Reporting Period:
2019-10-21
Accepted Time:
2019-10-21 16:23:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1553643 Relmada Therapeutics Inc. RLMD Pharmaceutical Preparations (2834) 455401931
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1658369 Maged Shenouda C/O Relmada Therapeutics, Inc.
880 Third Avenue, 12Th Floor
New York NY 10022
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-10-21 978 $23.00 2,228 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct